Melatonin Protects Against Thoracic Aortic Aneurysm and Dissection Through SIRT1-dependent Regulation of Oxidative Stress and Vascular Smooth Muscle Cell Loss.
Lin Xia,Chang Sun,Hanzhao Zhu,Mengen Zhai,Liyun Zhang,Liqing Jiang,Peng Hou,Junfeng Li,Kaifeng Li,Zhenhua Liu,Buying Li,Xiaowu Wang,Wei Yi,Hongliang Liang,Zhenxiao Jin,Jian Yang,Dinghua Yi,Jincheng Liu,Shiqiang Yu,Weixun Duan
DOI: https://doi.org/10.1111/jpi.12661
2020-01-01
Journal of Pineal Research
Abstract:Melatonin functions as an endogenous protective molecule in multiple vascular diseases, whereas its effects on thoracic aortic aneurysm and dissection (TAAD) and underlying mechanisms have not been reported. In this study, TAAD mouse model was successfully induced by beta-aminopropionitrile fumarate (BAPN). We found that melatonin treatment remarkably prevented the deterioration of TAAD, evidenced by decreased incidence, ameliorated aneurysmal dilation and vascular stiffness, improved aortic morphology, and inhibited elastin degradation, macrophage infiltration, and matrix metalloproteinase expression. Moreover, melatonin blunted oxidative stress damage and vascular smooth muscle cell (VSMC) loss. Notably, BAPN induced a decrease in SIRT1 expression and activity of mouse aorta, whereas melatonin treatment reversed it. Further mechanistic study demonstrated that blocking SIRT1 signaling partially inhibited these beneficial effects of melatonin on TAAD. Additionally, the melatonin receptor was involved in this phenomenon. Our study is the first to report that melatonin exerts therapeutic effects against TAAD by reducing oxidative stress and VSMC loss via activation of SIRT1 signaling in a receptor-dependent manner, thus suggesting a novel therapeutic strategy for TAAD.